DNA repair and cancer stem-like cells – Potential partners in glioma drug resistance?
- 31 October 2008
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 34 (6), 558-567
- https://doi.org/10.1016/j.ctrv.2008.03.125
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesCancer Research, 2007
- Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide TreatmentClinical Cancer Research, 2007
- HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and TumorigenicityCurrent Biology, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- ATR Kinase Activation Mediated by MutSα and MutLα in Response to Cytotoxic O6-Methylguanine AdductsMolecular Cell, 2006
- The multifaceted mismatch-repair systemNature Reviews Molecular Cell Biology, 2006
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- The Ways of PARPCell, 2004
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003